MedTrace Logo

Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases

NCT02735941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2018-07-30

No results posted yet for this study

Summary

The purpose of the study is to investigate phospholipid ligands and their receptors in inflammatory bowel diseases and colon cancer. Several new species of lipids have been recently discovered which are able to transmit information to cancer cells in the large intestine. The lipids and their responsive receptors build an axis that is thought to influence the development of inflammation and cancer.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Rudolf Schicho, PhD · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-13
Primary Completion
2018-07-27
Completion
2018-07-27

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02735941 on ClinicalTrials.gov